For the Inventor, By the Inventor

Enter assignee name

Beverly, MA, United States of America

Akston Biosciences Corporation

USPTO Granted Patents = 20

CIPO Patents = 5

EPO Patents = 7

Trademarks = 5

Forward Citations = 115

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Todd C Zion (20 out of 47 patents)

Thomas M Lancaster (20 out of 45 patents)

Thillainayagam Sathiyaseelan (4 out of 5 patents)

4. Sylaja Murikipudi (2 out of 3 patents)

5. Kexin Huang (2 out of 6 patents)

20 patents: Sort by Forward Citations

1. 12454565 - PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of use (2025-10-28),

2. 12195511 - Ultra-long acting insulin-Fc fusion protein (2025-01-14),

3. 11919935 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2024-03-05),

4. 11814418 - Ultra-long acting insulin-Fc fusion protein and methods of use (2023-11-14),

5. 11773151 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2023-10-03),

6. 11707517 - Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use (2023-07-25),

7. 11673934 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2023-06-13),

8. 11667689 - Insulin-Fc fusion proteins and methods of use to treat cancer (2023-06-06),

9. 11555058 - Cells engineered to express ultra-long acting insulin-Fc fusion proteins (2023-01-17),

10. 11359001 - Insulin-Fc fusions and methods of use (2022-06-14),

11. 11352407 - Ultra-long acting insulin-Fc fusion proteins (2022-06-07),

12. 11267862 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2022-03-08),

13. 11261229 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2022-03-01),

14. 11213581 - Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use (2022-01-04),

15. 11198719 - Ultra-long acting insulin-Fc fusion protein and methods of use (2021-12-14),

Akston Biosciences Corporation is a leading biotechnology company specializing in the development of innovative healthcare solutions. Our mission is to transform healthcare by harnessing the power of cutting-edge research and technology to develop novel diagnostics, therapeutics, and vaccines. With a focus on infectious diseases, our team of experienced scientists and researchers strive to create advanced solutions that improve patient outcomes and bring lasting impact to global health. Visit our website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

20 Patents

#10 in Beverly, MA

#941 in Massachusetts

#15,856 in US

#30,316 in the World

Beverly, MA, United States of America

Akston Biosciences Corporation

Forward Citations = 115

9 inventors:

Todd C Zion (20 out of 47 patents)

Thomas M Lancaster (20 out of 45 patents)

Thillainayagam Sathiyaseelan (4 out of 5 patents)

4. Sylaja Murikipudi (2 out of 3 patents)

5. Kexin Huang (2 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…